Neuronetics Inc. stock grades by Barron's. View STIM fundamental and sentiment analysis powered by MarketGrader.

Neuronetics Inc. research and ratings by Barron's. View STIM revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

MALVERN, Pa., June 19, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve ...

MALVERN, Pa., June 02, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of ...

MALVERN, Pa., June 19, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve ...

MALVERN, Pa., June 19, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve ...

MALVERN, Pa., June 19, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve ...

Neuronetics, Inc. announced the granting of inducement awards to a new non-executive employee, Jeff Jones, as part of its efforts to enhance the team's capabilities in addressing neurohealth ...

MALVERN, Pa., June 19, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that ...

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635 (c) (4) Provided by GlobeNewswire Jun 19, 2025, 4:00:56 PM ...

In accordance with NASDAQ Listing Rule 5635 (c) (4), these awards were approved by Neuronetics' Compensation Committee and made as a material inducement to their respective employment with the ...